trial · primary record
Remigromig
Diabetic Macular Edema (DME)
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1054 |
| Primary completion | 2028-01-11 |
| Primary endpoint | Change from baseline in Best-Corrected Visual Acuity (BCVA) measured using the standardized Early Treatment of Diabetic Retinopathy Study (ETDRS) chart |
| Registry ID | NCT06957080 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:51.560Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06957080
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.